Virginia Legislature Passes 340B Bill, One of at Least 14 States With 340B Legislation This Year

Virginia General Assembly building and grounds
The Virginia House of Delegates and Senate both overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions in the state.

The Virginia General Assembly has passed legislation to stop insurers and their pharmacy benefit managers (PBMs) from discriminating against 340B grantee covered entities and their contract pharmacies. Hospitals would be excluded from protection.

Virginia health centers say Gov. Glenn Youngkin

Read More »

Health Care Provider Groups Slam Gilead’s Conditions on 340B Contract Pharmacy

prescription bottle of Harvoni and pill
Harvoni is one of the four hepatitis C drugs that will face restrictions under Gilead's new 340B contract pharmacy policy.

HIV/AIDS clinics and hospitals that participate in the 340B program are condemning drug manufacturer Gilead’s new conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

Ryan White Clinics for 340B Access (RWC-340B) said

Read More »

For 2-3 Years, CMS Could Pay 340B Hospitals More for Pricey New Alzheimer’s Drug Than Current Norm

A box and bottle of prescription drug Aduhelm
MedPAC says that for two or three years CMS likely would pay 340B hospitals more for the expensive new Alzheimer's drug Aduhelm than it normally would for a Part B drug.

Medicare likely would pay 340B hospitals 106% of the average sales price (ASP) for Aduhelm—Biogen’s high-cost biologic drug for early-stage Alzheimer’s disease—for the first two or three years it is on the market, not the ASP minus 22.5% 340B hospital

Read More »

CMS Asks Judge to Dismiss 340B Health Centers’ Claims in Suit Over Medicaid Drug Benefits Transfer

A California benefits identification card
CMS told a judge last week it "has no authority to second-guess California’s decision" to transfer Medicaid managed care drug benefits to Medicaid fee for service.

The U.S. Centers for Medicare & Medicaid Services (CMS) asked a federal district judge in Sacramento last week to dismiss California health centers’ claims for relief over CMS’s approval of the state’s transfer of Medicaid managed care drug benefits to

Read More »

News Alert

Gilead Announces 340B Contract Pharmacy Restrictions that Apply to Hospital and Grantee Entities

Gilead building sign
Gilead is requiring 340B covered entities to supply claims data for its branded hepatitis C products to be able to continue to be eligible for bill to / ship to orders for multiple contract pharmacies.

Gilead late yesterday imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies. It is the 15th manufacturer to place restrictions on its 340B contract pharmacy program.

The policy, which applies to hospital

Read More »

Judge Clears Way for Feds to Appeal His Ruling in AstraZeneca’s 340B Contract Pharmacy Lawsuit

AstraZeneca building-mounted sign
A federal judge has cleared the way for the federal government to appeal his decision in AstraZeneca's 340B contract pharmacy lawsuit.

A federal district judge on Friday entered his final orders and judgement in AstraZeneca’s 340B contract pharmacy lawsuit, clearing the way for the government to file its anticipated appeal.

Judge Leonard Stark of the District of Delaware closed the first

Read More »

Biden to Sign Bill Today Giving Some Relief to Hospitals Forced Out of 340B Due to COVID-19

President Biden signing legislation in the Oval Office
President Biden is due to sign legislation this afternoon that will help some hospitals forced out of the 340B program during the COVID-19 pandemic.

President Biden is scheduled this afternoon to sign a $1.5 trillion federal appropriations bill with language to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The bill also gives the U.S. Health Resources and Services

Read More »

Economists Say 340B Hospital and Grantee Entities Use Contract Pharmacy for Different Reasons

pharmacist sorts pills
A new study finds that contract pharmacy growth patterns differ between 340B hospital and non-hospital entities.

Contract pharmacy growth patterns differ between 340B hospital and non-hospital entities, suggesting they may use 340B differently and should be subject to different 340B rules, new research in the American Journal of Managed Care concludes.

The authors, who previously have

Read More »

Drugmakers Janssen and Kala Providing Refunds for 340B Overcharges

Janssen Pharmaceutical companies of Johnson & Johnson exterior building sign
Janssen is providing refunds for 340B overcharges on four drugs during Q3 and Q4 2019.

Janssen Pharmaceuticals is giving 340B entities refunds for overcharges on 14 NDCs during the third and fourth quarters of 2019, according to a public notice on the U.S. Health Resources and Services Administration (HRSA) website.

“The revisions were due to

Read More »

News Alert

U.S. Senate OK’s Limited Relief for Hospitals Forced Out of 340B Due to COVID-19

U.S Senate chamber seen from public gallery
The U.S. Senate gave final passage last night to legislation to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The U.S. Senate last night passed a $1.5 trillion federal appropriations bill with language to help some hospitals forced out of the 340B program during the COVID-19 pandemic.

The House passed the bill Wednesday night. President Biden is expected

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live